[Clinical experimentation on a new analgesic with anti-inflammatory effect: N-(2,3-xylyl)-anthranilic acid].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000700:Analgesics / Q000008:administration & dosage / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008528:Mefenamic Acid / Q000008:administration & dosage / Q000627:therapeutic use; D008875:Middle Aged; D062367:ortho-Aminobenzoates
D000700:Analgesics; D000893:Anti-Inflammatory Agents; D062367:ortho-Aminobenzoates; D008528:Mefenamic Acid
Sulla sperimentazione clinica di un nuovo analgesico ad attività antinflammatoria: l'acido N-(2,3-xilil)-antranilico.